go to contents go to 1depth menu
Aiming to be a global drug maker

RESEARCH AREA

We will introduce about the various research areas of inno.N

IN-C001,
IN-C002,
IN-C003,
IN-C004,
IN-C005
IN-C019 IN-C009,
IN-C011,
IN-C012,
IN-C013,
IN-C014
IN-C006,
IN-C007
IN-C008
Incrementally
Modified Drug
Hypertension,
Hyperlipidemia
Gastroesophageal
reflux disease
Etc. Diabetes Nutrition

inno.N is developing incrementally modified drugs based on fixed dose combinations, including the first generic product, and the drug delivery system (DDS).
It is commercializing products by mainly concentrating on pharmaceutical classes, such as the circulatory system and the endocrine system, based on research and pilot facilities with guaranteed quality. With its distinguished drug delivery system, inno.N will continue to develop products that can meet the unmet needs of the market.